Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$193.75 - $232.55 $436,906 - $524,400
2,255 New
2,255 $524,000
Q2 2022

Aug 10, 2022

SELL
$181.58 - $368.0 $2.09 Million - $4.24 Million
-11,515 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$303.87 - $423.8 $457,020 - $637,395
1,504 Added 15.02%
11,515 $4.02 Million
Q4 2021

Feb 09, 2022

BUY
$347.28 - $421.83 $140,648 - $170,841
405 Added 4.22%
10,011 $3.81 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $460,367 - $595,693
1,135 Added 13.4%
9,606 $3.9 Million
Q2 2021

Aug 16, 2021

BUY
$372.84 - $481.5 $3.16 Million - $4.08 Million
8,471 New
8,471 $4.01 Million
Q4 2019

Feb 14, 2020

SELL
$288.29 - $335.49 $3.94 Million - $4.59 Million
-13,670 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$266.84 - $378.23 $1.27 Million - $1.79 Million
-4,743 Reduced 25.76%
13,670 $4.16 Million
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $144,884 - $177,448
482 Added 2.69%
18,413 $6.78 Million
Q1 2019

May 15, 2019

SELL
$272.57 - $321.18 $40,885 - $48,177
-150 Reduced 0.83%
17,931 $5.57 Million
Q4 2018

Feb 14, 2019

SELL
$272.46 - $366.54 $794,493 - $1.07 Million
-2,916 Reduced 13.89%
18,081 $5.42 Million
Q3 2018

Nov 14, 2018

SELL
$279.04 - $367.06 $64,179 - $84,423
-230 Reduced 1.08%
20,997 $7.71 Million
Q2 2018

Aug 13, 2018

SELL
$228.17 - $292.07 $63,887 - $81,779
-280 Reduced 1.3%
21,227 $5.93 Million
Q1 2018

May 15, 2018

BUY
$209.54 - $253.91 $348,884 - $422,760
1,665 Added 8.39%
21,507 $5.09 Million
Q4 2017

Feb 14, 2018

BUY
$202.23 - $230.03 $1.55 Million - $1.77 Million
7,682 Added 63.17%
19,842 $4.34 Million
Q3 2017

Nov 14, 2017

BUY
$172.3 - $213.93 $2.1 Million - $2.6 Million
12,160
12,160 $2.42 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Gardner Lewis Asset Management L P Portfolio

Follow Gardner Lewis Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gardner Lewis Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Gardner Lewis Asset Management L P with notifications on news.